Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA CA&E releases Antibiotic Amnesty 2024 results
This year saw practices also drawing attention to the return of other medications.
The results were shared at this year’s BSAVA Congress.

The Responsible use of Medicines Alliance – Companion Animal and Equine (RUMA CA&E) has shared the statistics from Antibiotic Amnesty 2024, which took place last November.

During a press conference on 20 March 2025, RUMA CA&E revealed that 2,413 antibiotics, including tablets, topicals and injections, had been returned to participating practices during the campaign.

Antibiotic Amnesty 2024 marks the third year of RUMA CA&E’s One Health campaign. It aims to combat the inappropriate use or disposal of antibiotics, which can otherwise contribute to antimicrobial resistance.

RUMA CA&E says that, although 12 per cent fewer antibiotics were returned compared to 2023, it is still a significant total. Statistics showed that 2,148 tablets, 136 topicals, 47 injections and 82 liquids were returned throughout November 2024.

While the campaign is generally focused on the return of antibiotics, this year also saw practices lead discussions on the return of other medications.

Although no formal data was collected, many practices took the opportunity to extend the conversation to other unused veterinary medicines. Among the other medications returned were parasticides and hormones.

There were also reports of human drugs, including antacids and contraceptive pills, being returned during the campaign.

RUMA CA&E describes its survey as a ‘snapshot’ of the campaign, with its survey evaluation being a voluntary process for those who took part. It is considered likely that a greater number of practices did take part in the campaign, since there was a high number of practices which signed up for campaign information.

This year 333 additional practices signed up for information about the Antibiotic Amnesty campaign, bringing the total number of practices receiving campaign information to 650 practices. The volume of traffic to the campaign website also increased by 35 per cent compared to 2023.

Steve Howard, RUMA CA&E secretary general, said: “What is also pleasing to hear is that antimicrobial stewardship is becoming embedded into everyday language and behaviours in the practice environment, with a number of practices attributing the reduced level of returned antibiotics to the fact that less are being prescribed in the first place, plus the ongoing focus to educate owners about the safe use and disposal of animal medicines.

“I would like to thank the profession once again for supporting the Antibiotic Amnesty so enthusiastically.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.